Insmed Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
© -
Okay. Hey, everybody. I'm Marty Auster, SMID cap biotech analyst here at Crédit Suisse. Welcome to our session with Will Lewis, President and CEO of Insmed.
Will, we're going to talk about a lot of topics. Most of them are going to be NTM, MAC and ARIKAYCE related, but thanks for coming.
Questions & Answers
© -
And maybe if you want to just kind of make a -- just a brief kind of statement to catch us up on kind of what's happened in '19, and kind of what you're proud of, what you're looking forward to in 2020 and beyond and I have a bunch of specific -- more specific questions to dig into probably from there.
Thanks very much. I think 2019 can best be summarized as just an outstanding first year of our product launch,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
